Medtronic Fidelis Lead Failure Rate Climbs, But New Software May Help
This article was originally published in The Gray Sheet
Executive Summary
Medtronic hopes new software for monitoring the integrity of implantable cardioverter defibrillator leads will allay physicians' and patients' fears about the high failure rate of the firm's Fidelis leads